Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:
A graphic of the flag of Australia alt
A graphic of the flag of Argentina alt
A graphic of the flag of Brazil alt
A graphic of the national flag of Canada alt
A graphic of the flag of Chile alt
A graphic of the national flag of the People's Republic of China alt
A graphic of the national flag of Colombia alt
A graphic of the national flag of Ecuador alt
A graphic of the flag of Germany alt
A graphic of the national flag of India alt
A graphic of the national flag of Japan alt
A graphic of the flag of Mexico alt
A graphic of the flag of Paraguay alt
A graphic of the flag of Peru alt
A graphic of the flag of Russia alt
Switzerland
A graphic of the flag of Switzerland alt
A graphic of the national flag of Uruguay alt
A graphic of the flag of Venezuela alt
Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
49
Latest News

What You Need to Know About Johnson & Johnson's 2021 Second-Quarter Earnings

Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
49
Check out this infographic breakdown of the company’s second-quarter 2021 performance, with key highlights from its Pharmaceutical, Consumer Health and Medical Device businesses.
Today's Top Reads Close
Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
49
expand

This morning, Johnson & Johnson shared its second-quarter performance.

Since its founding in 1886, the company has grown to become one of the world's largest and most broadly based healthcare companies, with approximately 136,000 employees across the globe working every day to help change the trajectory of health for humanity.

“Johnson & Johnson’s second-quarter results were driven by strong performance across our three business units, exceeding expectations," says Joe Wolk Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson, Executive Vice President and Chief Financial Officer, Johnson & Johnson. "Continued market recovery favorably impacted growth comparisons as our Pharmaceutical, Medical Device and Consumer Health businesses improved their market-leading positions across many platforms. This performance underscores the resilience of our diversified business, in addition to the agility of our colleagues to meet the needs of patients and consumers around the world. We are poised to continue our pursuit of improving human health and the well-being of people around the world while delivering long-term value to all of our stakeholders well beyond 2021.”

For more details about the company's 2021 second-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky Johnson & Johnson Chairman and CEO Alex Gorsky Alex Gorsky,Chairman and Chief Executive Officer, Johnson & Johnson, here's an infographic that highlights key stats.


Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
49
expand 2021 Johnson & Johnson Q2 Earnings Infographic

Read the earnings press release, which includes full financial details for the second quarter of 2021.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
49

More from Johnson & Johnson

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue